Hemodynamic Impact of the Administration of PAracetamol in Patients Hospitalized in the Intensive Resuscitation Medicine Department [PAREA]
PAREA
Prospective Study Evaluating the Hemodynamic Impact of PAracetamol Administration in Patients Hospitalized in the REAnimation Intensive Care Unit
1 other identifier
interventional
200
1 country
1
Brief Summary
Paracetamol is commonly used in case of pain or fever. Few previously clinical studies has highlighted an arterial hypotension linked to intravenous administration of paracetamol. Currently, fewer data are available on the link of intravenous administration of paracetamol and effects on arterial tension. The aim of this study is to describe the frequency of occurrence of significative arterial hypotension within one hour following intravenous or per os administration of paracetamol . Other factors who can be associated to occurence of significative arterial hypotension will be also observe (for example age, weight, pain, vasopressor dosage or sedative...)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2024
CompletedFirst Posted
Study publicly available on registry
May 28, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
May 29, 2024
May 1, 2024
2.5 years
May 16, 2024
May 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measure frequency of low blood pressure following paracetamol administration
Proportion of patients with clinically significant low blood pressure occurring within one hour of administration of paracetamol IV or per os. Clinically significant low blood pressure is defined as an average blood pressure of less than 60 mmHg and/or a decrease in average blood pressure of more than 15%, and/or need for vascular filling and/or initiation or increase of the dose of noradrenaline
One hour after administration of paracetamol
Secondary Outcomes (4)
Measure of blood pressure following paracetamol administration according to IGS II score
One hour after administration of paracetamol
identify predictors linked to paracetamol administration route
One hour after administration of paracetamol
identify predictors linked to paracetamol dosage
One hour after administration of paracetamol
Measure of blood pressure following paracetamol administration according to SOFA score
One hour after administration of paracetamol
Study Arms (1)
Treatment with paracetamol
EXPERIMENTALInterventions
Patient hospitalized in Intensive Care Unit with a continuous measurement of blood pressure with a catheter and who have an administration of paracetamol by intravenous or per os
Eligibility Criteria
You may qualify if:
- years of age or older
- Patient with arterial catheter
- Indication of paracetamol's administration by the patient's attending practitioner.
- No opposition to patient or support person participation in the study if the patient is unable to participate
- No Social Security Patient
- Pregnant or nursing patient.
- Patient with a legal protection measure
- Hypersensitivity and/or allergy to paracetamol.
- Contraindication to the use of paracetamol.
- Patient opposition to health data collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de NICE ARCHET
Nice, 06000, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2024
First Posted
May 28, 2024
Study Start
June 1, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
April 1, 2027
Last Updated
May 29, 2024
Record last verified: 2024-05